01.09.24
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch + Lomb), and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals). They also share some practice pearls and professional goals for the year ahead.
View full description +
Subscribe
08.13.25
Building Out a Dry Eye and Aesthetics PracticeJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Shane Swatts, OD
07.08.25
Takeways From the TFOS DEWS III ReportJackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO; and Vin T. Dang, OD, FAAO
06.11.25
A Lesson in Blink Mechanics and Dry EyeJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Cory J. Lappin, OD, MS, FAAO
05.12.25
Is it Dry Eye or Corneal Pathology?Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Bita Asghari, OD, FAAO, FSLS
04.09.25
Take Ownership of Your Career in Dry EyeJackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO
03.11.25
Learn How Vitamin A Supports the Ocular SurfaceJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Kaleb Abbott, OD, FAAO
02.10.25
Beware the Dry Eye MasqueradersJackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Mile Brujic, OD, FAAO
01.02.25
OSD’s Greatest Hits: 2024 EditionJackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO
Show More